by EpicentRx | Oct 10, 2024 | Blog
The intriguing premise of a new Apple TV sci-fi-thriller, Dark Matter, based on a best-selling novel of the same name is that myriad parallel universes or multiverses constantly arise from all possible choices, or decisions, which are made or not made. The show’s...
by EpicentRx | Oct 9, 2024 | Blog
The United States Adopted Names (USAN) Council and the World Health Organization (WHO) INN Programme gave RRx-001 the generic name, nibrozetone, as we have written about before here in this blog post entitled, “Coppertone or Nibrozetone”, since nibrozetone sounds like...
by EpicentRx | Oct 8, 2024 | Blog
Cisplatin/70 Gy IMRT confirmed as standard of care (SOC) for nonsmoking HPV+ oropharyngeal cancer, which is the treatment used in the Phase 2/3 clinical trial, KEVLARx, that features the EpicentRx lead small molecule, RRx-001 (nibrozetone). According to the results of...
by EpicentRx | Oct 7, 2024 | Blog
“Do not ever traduce the good name of Words of the Week.” “Mrs. Robinson, are you trying to traduce me?” Traduce Definition (verb): 1) Slander, malign, badmouth “So traduced was the congressman by reports of sexual misconduct that he was forced to resign”; “The...
by EpicentRx | Oct 4, 2024 | Blog
The first meeting of the minds occurred on Saturday, September 28th from 1:30-2:30 pm EST at the 2024 International Congress of Parkinson’s Disease and Movement Disorders (MDS) in Philadelphia, Pennsylvania. During a one-hour platform presentation, Associate Professor...
